Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.62 |
| ▸ | MAPT | P10636 | 1/20 | 0.62 |
| ▸ | MEP1B | Q16820 | 2/20 | 0.52 |
| ▸ | MME | P08473 | 1/20 | 0.51 |
| ▸ | CPA1 | P15085 | 2/20 | 0.50 |
| ▸ | CPB1 | P15086 | 1/20 | 0.50 |
| ▸ | CPA3 | P15088 | 1/20 | 0.50 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | RAB9A | P51151 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | ACP3 | P15309 | 2/20 | 0.45 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.44 |
| ▸ | MMP8 | P22894 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL60484 | 1.00 | GAA (0.62) | GAAMAPTMEP1BMMECPA1 | |
| SCHEMBL31267566 | 1.00 | GAA (0.62) | GAAMAPTMEP1BMMECPA1 | |
| Ethylene Glycol SCHEMBL28010670 | 0.95 | GAA (0.57) | GAAMAPTMEP1BMMECPA1 | |
| SCHEMBL12311004 | 0.92 | GAA (0.53) | GAAMAPTMEP1BMMECPA1 | |
| Pyridine SCHEMBL28100146 | 0.91 | GAA (0.54) | GAAMAPTMEP1BMMECPA1 | |
| Tridecane SCHEMBL29056190 | 0.88 | TLR2 (0.56) | GAAMAPT | |
| SCHEMBL24024007 | 0.86 | GAA (0.51) | GAAMAPTMEP1BMMECPA1 | |
| SCHEMBL8065316 | 0.86 | ALDH1A1 (0.64) | GAAMAPTALDH1A1RAB9APOLB | |
| SCHEMBL31396961 | 0.86 | MAPT (0.48) | GAAMAPTMEP1BALDH1A1RAB9A | |
| SCHEMBL9554646 | 0.86 | ALDH1A1 (0.64) | GAAMAPTALDH1A1RAB9APOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 274 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115888659-B | New preparation method of macroporous cyclodextrin microsphere for flavone separation | 四川聚豪锦悦农林科技有限公司 | 2024-03-01 | — | — | CN | claimed |
| CN-116459359-A | Rare earth nano fluorescence-nuclear medicine tumor imaging treatment integrated preparation, preparation method, use method and application thereof | 中国科学院福建物质结构研究所 | 2023-07-21 | — | — | CN | claimed |
| CN-115888659-A | Novel preparation method of macroporous cyclodextrin microspheres for separating flavone | 四川聚豪锦悦农林科技有限公司 | 2023-04-04 | — | — | CN | claimed |
| CN-113135983-B | Antitumor compound and preparation method thereof | 四川大学华西医院 | 2022-06-24 | — | — | CN | claimed |
| CN-113135983-A | Antitumor compound and preparation method thereof | 四川大学华西医院 | 2021-07-20 | — | — | CN | claimed |
| CN-111529487-A | Coenzyme Q10 series compound-loaded polymer micelle and preparation method and application thereof | 四川大学华西医院 | 2020-08-14 | — | — | CN | claimed |
| CN-111135145-A | Preparation process of polyethylene glycol micelle with high drug loading | 福建齐衡科技有限公司 | 2020-05-12 | — | — | CN | claimed |
| CN-110893172-A | Elemene polymer micelle preparation and preparation method and application thereof | 四川省人民医院 | 2020-03-20 | — | — | CN | claimed |
| US-8921258-B2 | Catalyst for selective oxidation of NH3 to N2 and method for preparing the same | SK INNOVATION CO., LTD. (KR) | 2014-12-30 | — | — | US | claimed |
| US-20130224090-A1 | CATALYST FOR SELECTIVE OXIDATION OF NH3 TO N2 AND METHOD FOR PREPARING THE SAME | SK INNOVATION CO., LTD. (KR) | 2013-08-29 | — | — | US | claimed |
| CN-102740966-A | Catalyst for selective oxidation of nh3 to n2 and method for preparing the same | SK INNOVATION CO LTD | 2012-10-17 | — | — | CN | claimed |
| CN-102614152-A | Method for preparing vesicle medicinal nanoparticles | UNIV HENAN | 2012-08-01 | — | — | CN | claimed |
| WO-2011062390-A2 | CATALYST FOR SELECTIVE OXIDATION OF NH3 TO N2 AND METHOD FOR PREPARING THE SAME | SK INNOVATION CO., LTD. (KR) | 2011-05-26 | — | — | WO | claimed |
| CN-1170821-C | Preparation of naphthenic acid | DSM IP �ʲ�����˾ | 2004-10-13 | — | — | CN | claimed |
| CN-1286249-A | Preparation of naphthenic acid | HOFFMANN LA ROCHE (CH) | 2001-03-07 | — | — | CN | claimed |
| CN-106119113-B | Organisms for the production of 1, 3-butanediol | 基因组股份公司 | 2026-05-12 | — | — | CN | disclosed |
| US-20250361531-A1 | MICROORGANISMS AND METHODS FOR PRODUCTION OF 4-HYDROXYBUTYRATE, 1,4-BUTANEDIOL AND RELATED COMPOUNDS | AGAIN BIO APS (DK) | 2025-11-27 | — | — | US | disclosed |
| EP-0079934-A1 | ANTIGENIC LINEAR PEPTIDE COMPOUNDS. | UNIV NORTHWESTERN (US) | 1983-06-01 | — | — | EP | disclosed |
| WO-1982004250-A1 | ANTIGENIC LINEAR PEPTIDE COMPOUNDS | UNIV NORTHWESTERN (US) | 1982-12-09 | — | — | WO | disclosed |
| US-4301045-A | RESIN PEPTIDES | ARMOUR PHARMACEUTICAL COMPANY (US) | 1981-11-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250361531-A1 | MICROORGANISMS AND METHODS FOR PRODUCTION OF 4-HYDROXYBUTYRATE, 1,4-BUTANEDIOL AND RELATED COMPOUNDS | HSD17B10, HSD17B12, HADHB | GAA 2065/4885MAPT 3211/4885MEP1B 755/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.